Fibroblastic tumors of intermediate malignancy in childhood.

about

Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene.

P2860

Q36276051-174EABA1-6AFA-4CA1-A0FC-4B508C2AD678

P2860

Fibroblastic tumors of intermediate malignancy in childhood.

Item

http://www.wikidata.org/entity/Q38081247

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Fibroblastic tumors of intermediate malignancy in childhood.

@en

type

Item

label

Fibroblastic tumors of intermediate malignancy in childhood.

@en

prefLabel

Fibroblastic tumors of intermediate malignancy in childhood.

@en

P1476

Fibroblastic tumors of intermediate malignancy in childhood.

@en

P2093

Elena Cavaliere

http://www.w3.org/2001/XMLSchema#string

Gianni Bisogno

http://www.w3.org/2001/XMLSchema#string

Marco Vajna de Pava

http://www.w3.org/2001/XMLSchema#string

Rita Alaggio

http://www.w3.org/2001/XMLSchema#string

P2860

Activity of Sorafenib against desmoid tumor/deep fibromatosis

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

Congenital infantile fibrosarcoma: a masquerader of ulcerated hemangioma.

Infantile fibrosarcoma: management based on the European experience.

High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management.

Desmoid disease in patients with familial adenomatous polyposis.

Long-term results with radiation therapy for pediatric desmoid tumors.

Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review.

Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial.

Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation.

P304

225-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERA.12.180

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23406563

http://www.w3.org/2001/XMLSchema#string

Fibroblastic tumors of intermediate malignancy in childhood.

about

P2860

P2860

Fibroblastic tumors of intermediate malignancy in childhood.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698